Global Gliclazide Sustained-release Tablet Market Research Report 2023

The global Gliclazide Sustained-release Tablet market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Gliclazide Sustained-release Tablet include Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare and Lukang Jituan Saite Yaoye, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gliclazide Sustained-release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gliclazide Sustained-release Tablet.

The Gliclazide Sustained-release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gliclazide Sustained-release Tablet market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gliclazide Sustained-release Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Gliclazide Sustained-release Tablet

1.2 Gliclazide Sustained-release Tablet Segment by Type

1.2.1 Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029)

1.2.2 30mg

1.2.3 60mg

1.2.4 Other

1.3 Gliclazide Sustained-release Tablet Segment by Application

1.3.1 Global Gliclazide Sustained-release Tablet Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Gliclazide Sustained-release Tablet Market Size Estimates and Forecasts

1.4.1 Global Gliclazide Sustained-release Tablet Revenue 2018-2029

1.4.2 Global Gliclazide Sustained-release Tablet Sales 2018-2029

1.4.3 Global Gliclazide Sustained-release Tablet Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2018-2023)

2.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Gliclazide Sustained-release Tablet Average Price by Manufacturers (2018-2023)

2.4 Global Gliclazide Sustained-release Tablet Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application

2.7 Gliclazide Sustained-release Tablet Market Competitive Situation and Trends

2.7.1 Gliclazide Sustained-release Tablet Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Gliclazide Sustained-release Tablet Players Market Share by Revenue

2.7.3 Global Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Gliclazide Sustained-release Tablet Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Gliclazide Sustained-release Tablet Global Gliclazide Sustained-release Tablet Sales by Region: 2018-2029

3.2.1 Global Gliclazide Sustained-release Tablet Sales by Region: 2018-2023

3.2.2 Global Gliclazide Sustained-release Tablet Sales by Region: 2024-2029

3.3 Global Gliclazide Sustained-release Tablet Global Gliclazide Sustained-release Tablet Revenue by Region: 2018-2029

3.3.1 Global Gliclazide Sustained-release Tablet Revenue by Region: 2018-2023

3.3.2 Global Gliclazide Sustained-release Tablet Revenue by Region: 2024-2029

3.4 North America Gliclazide Sustained-release Tablet Market Facts & Figures by Country

3.4.1 North America Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Gliclazide Sustained-release Tablet Sales by Country (2018-2029)

3.4.3 North America Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Gliclazide Sustained-release Tablet Market Facts & Figures by Country

3.5.1 Europe Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2029)

3.5.3 Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gliclazide Sustained-release Tablet Market Facts & Figures by Country

3.6.1 Asia Pacific Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Gliclazide Sustained-release Tablet Sales by Country (2018-2029)

3.6.3 Asia Pacific Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Gliclazide Sustained-release Tablet Market Facts & Figures by Country

3.7.1 Latin America Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Gliclazide Sustained-release Tablet Sales by Country (2018-2029)

3.7.3 Latin America Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Gliclazide Sustained-release Tablet Market Facts & Figures by Country

3.8.1 Middle East and Africa Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2029)

3.8.3 Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Gliclazide Sustained-release Tablet Sales by Type (2018-2029)

4.1.1 Global Gliclazide Sustained-release Tablet Sales by Type (2018-2023)

4.1.2 Global Gliclazide Sustained-release Tablet Sales by Type (2024-2029)

4.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2029)

4.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2018-2029)

4.2.1 Global Gliclazide Sustained-release Tablet Revenue by Type (2018-2023)

4.2.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2024-2029)

4.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2029)

4.3 Global Gliclazide Sustained-release Tablet Price by Type (2018-2029)

5.1 Global Gliclazide Sustained-release Tablet Sales by Application (2018-2029)

5.1.1 Global Gliclazide Sustained-release Tablet Sales by Application (2018-2023)

5.1.2 Global Gliclazide Sustained-release Tablet Sales by Application (2024-2029)

5.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2029)

5.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2018-2029)

5.2.1 Global Gliclazide Sustained-release Tablet Revenue by Application (2018-2023)

5.2.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2024-2029)

5.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2018-2029)

5.3 Global Gliclazide Sustained-release Tablet Price by Application (2018-2029)

6.1 Servier Laboratories

6.1.1 Servier Laboratories Corporation Information

6.1.2 Servier Laboratories Description and Business Overview

6.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio

6.1.5 Servier Laboratories Recent Developments/Updates

6.2 Torrent Pharmaceuticals

6.2.1 Torrent Pharmaceuticals Corporation Information

6.2.2 Torrent Pharmaceuticals Description and Business Overview

6.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio

6.2.5 Torrent Pharmaceuticals Recent Developments/Updates

6.3 Aurobindo Pharma

6.3.1 Aurobindo Pharma Corporation Information

6.3.2 Aurobindo Pharma Description and Business Overview

6.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio

6.3.5 Aurobindo Pharma Recent Developments/Updates

6.4 Teva

6.4.1 Teva Corporation Information

6.4.2 Teva Description and Business Overview

6.4.3 Teva Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Teva Gliclazide Sustained-release Tablet Product Portfolio

6.4.5 Teva Recent Developments/Updates

6.5 Zydus Cadila Healthcare

6.5.1 Zydus Cadila Healthcare Corporation Information

6.5.2 Zydus Cadila Healthcare Description and Business Overview

6.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio

6.5.5 Zydus Cadila Healthcare Recent Developments/Updates

6.6 Sanofi S.A.

6.6.1 Sanofi S.A. Corporation Information

6.6.2 Sanofi S.A. Description and Business Overview

6.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio

6.6.5 Sanofi S.A. Recent Developments/Updates

6.7 Mylan Pharmaceuticals

6.6.1 Mylan Pharmaceuticals Corporation Information

6.6.2 Mylan Pharmaceuticals Description and Business Overview

6.6.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio

6.7.5 Mylan Pharmaceuticals Recent Developments/Updates

6.8 Accord Healthcare

6.8.1 Accord Healthcare Corporation Information

6.8.2 Accord Healthcare Description and Business Overview

6.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio

6.8.5 Accord Healthcare Recent Developments/Updates

6.9 Lukang Jituan Saite Yaoye

6.9.1 Lukang Jituan Saite Yaoye Corporation Information

6.9.2 Lukang Jituan Saite Yaoye Description and Business Overview

6.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio

6.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates

6.10 Shijiazhuang SIYAO

6.10.1 Shijiazhuang SIYAO Corporation Information

6.10.2 Shijiazhuang SIYAO Description and Business Overview

6.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio

6.10.5 Shijiazhuang SIYAO Recent Developments/Updates

6.11 Yiling Pharmaceutical

6.11.1 Yiling Pharmaceutical Corporation Information

6.11.2 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Description and Business Overview

6.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio

6.11.5 Yiling Pharmaceutical Recent Developments/Updates

7.1 Gliclazide Sustained-release Tablet Industry Chain Analysis

7.2 Gliclazide Sustained-release Tablet Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gliclazide Sustained-release Tablet Production Mode & Process

7.4 Gliclazide Sustained-release Tablet Sales and Marketing

7.4.1 Gliclazide Sustained-release Tablet Sales Channels

7.4.2 Gliclazide Sustained-release Tablet Distributors

7.5 Gliclazide Sustained-release Tablet Customers

8.1 Gliclazide Sustained-release Tablet Industry Trends

8.2 Gliclazide Sustained-release Tablet Market Drivers

8.3 Gliclazide Sustained-release Tablet Market Challenges

8.4 Gliclazide Sustained-release Tablet Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Gliclazide Sustained-release Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Gliclazide Sustained-release Tablet Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Gliclazide Sustained-release Tablet Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Gliclazide Sustained-release Tablet Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Gliclazide Sustained-release Tablet, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application

    Table 12. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Gliclazide Sustained-release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliclazide Sustained-release Tablet as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Gliclazide Sustained-release Tablet Sales by Region (2018-2023) & (K Units)

    Table 18. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2018-2023)

    Table 19. Global Gliclazide Sustained-release Tablet Sales by Region (2024-2029) & (K Units)

    Table 20. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2024-2029)

    Table 21. Global Gliclazide Sustained-release Tablet Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2018-2023)

    Table 23. Global Gliclazide Sustained-release Tablet Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2024-2029)

    Table 25. North America Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)

    Table 27. North America Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)

    Table 28. North America Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2018-2023)

    Table 51. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2024-2029)

    Table 52. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)

    Table 53. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2024-2029)

    Table 54. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2023)

    Table 57. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2024-2029)

    Table 58. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2018-2023)

    Table 61. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2024-2029)

    Table 62. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)

    Table 63. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2024-2029)

    Table 64. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2018-2023)

    Table 67. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2024-2029)

    Table 68. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2024-2029)

    Table 70. Servier Laboratories Corporation Information

    Table 71. Servier Laboratories Description and Business Overview

    Table 72. Servier Laboratories Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Servier Laboratories Gliclazide Sustained-release Tablet Product

    Table 74. Servier Laboratories Recent Developments/Updates

    Table 75. Torrent Pharmaceuticals Corporation Information

    Table 76. Torrent Pharmaceuticals Description and Business Overview

    Table 77. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product

    Table 79. Torrent Pharmaceuticals Recent Developments/Updates

    Table 80. Aurobindo Pharma Corporation Information

    Table 81. Aurobindo Pharma Description and Business Overview

    Table 82. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Aurobindo Pharma Gliclazide Sustained-release Tablet Product

    Table 84. Aurobindo Pharma Recent Developments/Updates

    Table 85. Teva Corporation Information

    Table 86. Teva Description and Business Overview

    Table 87. Teva Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Teva Gliclazide Sustained-release Tablet Product

    Table 89. Teva Recent Developments/Updates

    Table 90. Zydus Cadila Healthcare Corporation Information

    Table 91. Zydus Cadila Healthcare Description and Business Overview

    Table 92. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product

    Table 94. Zydus Cadila Healthcare Recent Developments/Updates

    Table 95. Sanofi S.A. Corporation Information

    Table 96. Sanofi S.A. Description and Business Overview

    Table 97. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Sanofi S.A. Gliclazide Sustained-release Tablet Product

    Table 99. Sanofi S.A. Recent Developments/Updates

    Table 100. Mylan Pharmaceuticals Corporation Information

    Table 101. Mylan Pharmaceuticals Description and Business Overview

    Table 102. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product

    Table 104. Mylan Pharmaceuticals Recent Developments/Updates

    Table 105. Accord Healthcare Corporation Information

    Table 106. Accord Healthcare Description and Business Overview

    Table 107. Accord Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Accord Healthcare Gliclazide Sustained-release Tablet Product

    Table 109. Accord Healthcare Recent Developments/Updates

    Table 110. Lukang Jituan Saite Yaoye Corporation Information

    Table 111. Lukang Jituan Saite Yaoye Description and Business Overview

    Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product

    Table 114. Lukang Jituan Saite Yaoye Recent Developments/Updates

    Table 115. Shijiazhuang SIYAO Corporation Information

    Table 116. Shijiazhuang SIYAO Description and Business Overview

    Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product

    Table 119. Shijiazhuang SIYAO Recent Developments/Updates

    Table 120. Yiling Pharmaceutical Corporation Information

    Table 121. Yiling Pharmaceutical Description and Business Overview

    Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product

    Table 124. Yiling Pharmaceutical Recent Developments/Updates

    Table 125. Key Raw Materials Lists

    Table 126. Raw Materials Key Suppliers Lists

    Table 127. Gliclazide Sustained-release Tablet Distributors List

    Table 128. Gliclazide Sustained-release Tablet Customers List

    Table 129. Gliclazide Sustained-release Tablet Market Trends

    Table 130. Gliclazide Sustained-release Tablet Market Drivers

    Table 131. Gliclazide Sustained-release Tablet Market Challenges

    Table 132. Gliclazide Sustained-release Tablet Market Restraints

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Gliclazide Sustained-release Tablet

    Figure 2. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Gliclazide Sustained-release Tablet Market Share by Type in 2022 & 2029

    Figure 4. 30mg Product Picture

    Figure 5. 60mg Product Picture

    Figure 6. Other Product Picture

    Figure 7. Global Gliclazide Sustained-release Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Gliclazide Sustained-release Tablet Market Share by Application in 2022 & 2029

    Figure 9. Hospital

    Figure 10. Clinic

    Figure 11. Other

    Figure 12. Global Gliclazide Sustained-release Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Gliclazide Sustained-release Tablet Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Gliclazide Sustained-release Tablet Sales (2018-2029) & (K Units)

    Figure 15. Global Gliclazide Sustained-release Tablet Average Price (US$/Unit) & (2018-2029)

    Figure 16. Gliclazide Sustained-release Tablet Report Years Considered

    Figure 17. Gliclazide Sustained-release Tablet Sales Share by Manufacturers in 2022

    Figure 18. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players: Market Share by Revenue in 2022

    Figure 20. Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)

    Figure 23. North America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)

    Figure 24. United States Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)

    Figure 27. Europe Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Gliclazide Sustained-release Tablet Revenue Market Share by Region (2018-2029)

    Figure 35. China Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. China Taiwan Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Southeast Asia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Latin America Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)

    Figure 43. Latin America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)

    Figure 44. Mexico Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Brazil Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Argentina Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Colombia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. UAE Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Gliclazide Sustained-release Tablet by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Type (2018-2029)

    Figure 55. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Gliclazide Sustained-release Tablet by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Application (2018-2029)

    Figure 58. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2018-2029)

    Figure 59. Gliclazide Sustained-release Tablet Value Chain

    Figure 60. Gliclazide Sustained-release Tablet Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed